Edición especial COVID-19 Abril-Diciembre 2020 82
ISSN 1317-987X
 
Buscar




Artículos
 



Virología
Virus emergentes y reemergentes

Referencias

  1. Mahy, BWJ. 1997. Emerging virus infections. Virus International. No 6: Editorial.
  2. Kellam, P. 1998. Molecular identification of novel viruses. Trends Microbiol. 64: 160-165.
  3. Gubler, DJ y Kuno, G. 1997. Dengue and dengue hemorragic fever. Cab International. UK.
  4. Leitmeyer, KC, Vaughn ,DW, Watts, DM, Salas ,R, Villalobos de Chacon, I, Ramos, C y Rico-Hesse, R. 1999. Dengue virus structural differences that correlate with pathogenesis. J Virol. 73: 4738-4747.
  5. Kouri, GP, Guzmán, MG y Bravo, JR. 1987. Why dengue haemorragic fever in Cuba? 2. An integral analysis. Trans Roy Soc Trop Med Hyg. 81: 821-823.
  6. Gill, J, Stark, LM y Clark, GG. 1999. Dengue Surveillance in Florida, 1997-98. Emerg Infect Dis. 6(1). Available from: URL: http://www.cdc.gov/ncidod/eid/vol6no1/gill.htm
  7. Preston, R. 1994. The hot zone. A terryfying true story. Random House Inc. NY.
  8. Chepurnov, AA, Tuzova, MN, Ternovoy, VA, Chernukhin, IV. 1999. Suppressive effect of Ebola virus on T cell proliferation in vitro is provided by a 125-kDa GP viral protein. Immunol Lett. 68:257-261.
  9. Kindzelskii, AL, Yang, ZY, Nabel, GJ, Todd, RF y Petty, HR. 2000. Ebola Virus Secretory Glycoprotein (sGP) Diminishes FcRIIIB-to-CR3 Proximity on Neutrophils. The Journal of Immunology, 2000, 164: 953-958.
  10. Georges-Courbot, MC, Sanchez, A, Lu, CY, Baize, S, Leroy, E, Lansout-Soukate, J, Tevi-Benissan, C, Georges, AJ, Trappier, SG, Zaki, SR, Swanepoel, R, Leman, PA, Rollin, PE, Peters, CJ, Nichol, ST, Ksiazek, TG. 1997. Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon. Emerg Infect Dis. 3: 59-62. Available from: URL: http://www.cdc.gov/ncidod/eid/vol3no1/courbot2.htm
  11. Peters, CJ. 1997. Ebola and hantaviruses. FEMS Immunol Med Microbiol. 18: 281-289.
  12. Breman, JG, Johnson, KM, van der Groen, G, Robbins, CB, Szczeniowski, MV, Ruti, K, Webb, PA, Meier, F, Heymann, DL. 1999. A search for Ebola virus in animals in the Democratic Republic of the Congo and Cameroon: ecologic, virologic, and serologic surveys, 1979-1980. Ebola Virus Study Teams. J Infect Dis.179 Suppl 1:S139-S147.
  13. Hagmann, M. 1999. On the track of Ebola's hideout? Science. 286: 654-655.
  14. Morvan, JM, Deubel, V, Gounon, P, Nakoune, E, Barriere, P, Murri, S, Perpete, O, Selekon, B, Coudrier, D, Gautier-Hion, A, Colyn, M y Volehkov, V. 1999. Identification of Ebola virus sequences present as RNA or DNA in organs of terrestrial small mammals of the Central African Republic. Microbes Infect. 1: 1193-1201.
  15. Salas, R, de Manzione, N, Tesh, RB, Rico-Hesse, R, Shope, RE, Betancourt, A, Godoy, O, Bruzual, R, Pacheco, ME, Ramos, B, et al. 1991. Venezuelan haemorrhagic fever. Lancet. 338: 1033-1036.
  16. McCormick, JB, Webb, PA, Krebs, JW, Johnson, KM y Smith, ES. 1987. A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis. 155: 437-444.
  17. Salas, RA, de Manzione, N y Tesh, R. 1998. Fiebre hemorrágica venezolana: ocho años de observación. Acta Cient Venez. 49 Suppl 1:46-51.
  18. Hart, CA y Bennett, M. 1999. Hantavirus infections: epidemiology and pathogenesis. Microbes Infect. 1: 1229-1237.
  19. Calderon, G, Pini, N, Bolpe, J, Levis, S, Mills, J, Segura, E, Guthmann, N, Cantoni, G, Becker, J, Fonollat, A, Ripoll, C, Bortman, M, Benedetti, R y Enria, D. 1999. Hantavirus reservoir hosts associated with peridomestic habitats in Argentina. Emerg Infect Dis. 5: 792-797. Available from: URL: http://www.cdc.gov/ncidod/EID/vol5no6/calderonG.htm
  20. Fulhorst, CF, Monroe, MC, Salas, RA, Duno, G, Utrera, A, Ksiazek, TG, Nichol, ST, de Manzione, NM, Tovar, D y Tesh, RB. 1997. Isolation, characterization and geographic distribution of Cano Delgadito virus, a newly discovered South American hantavirus (family Bunyaviridae). Virus Res. 51:159-171.
  21. Snacken,R, Kendal, AP, Haaheim, LR y Wood, JM. 1997. The Next Influenza Pandemic: Lessons from Hong Kong. Emerg Infect Dis. 5(2). Available from: URL: http://www.cdc.gov/ncidod/EID/eid/col5no2/snacken.htm
  22. Wang, E, Barrera, R, Boshell, J, Ferro, C, Freier, JE, Navarro, JC, Salas, R, Vasquez, C y Weaver, S. 1999. Genetic and phenotypic changes accompanying the emergence of epizootic subtype IC venezuelan equine encephalitis viruses from an enzootic subtype ID progenitor. J. Virol. 73: 4266-4271.
  23. Gojobori, T, Moriyama, EN y Kimura, M. 1990. Molecular clock of viral evolution, and the neutral theory. Proc Natl Acad Sci USA. 87: 10015-10018.
  24. Hu, DJ, Dondero, TJ, Rayfield, MA, George, JR, Schochetman, G, Jaffe, HW, Luo, CC, Kalish, ML, Weniger, BG, Pau, CP, Schable, CA y Curran, JW. 1996. The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research, and prevention. JAMA. 275: 210-216.
  25. McCutchan, FE, Salminen, MO, Carr, JK y Burke, DS . 1996. HIV-1 genetic diversity. AIDS. Suppl 3:S13-20.
  26. Gao, F, Bailes, E, Robertson, DL, Chen, Y, Rodenburg, CM, Michael, SF, Cummins, LB, Arthur, LO, Peeters, M, Shaw, GM, Sharp, PM y Hahn, BH. 1999. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature. 397: 436-441.
  27. Chang, Y, Cesarman, E, Pessin, MS, Lee, F, Culpepper, J, Knowles, DM y Moore, PS. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 266: 1865-1869.
  28. Reitz, MS Jr, Nerurkar, LS y Gallo, RC. 1999. Perspective on Kaposi's sarcoma: facts, concepts, and conjectures. J Natl Cancer Inst. 91:1453-1458.
  29. Bergstom, T. 1999. HHV 6,7 ans 8. Recently discovered herpesvirus explain the etiology of well-known diseases. Lakartidningen. 96 : 3163-3165.
  30. Diosi, P. 1995. 100 years of cytomegalovirus research: an overview. Rom J Virol. 46: 75-84.
  31. Miyamura, T, Takeda, N y Matsuura, Y. 1997. Emerging and re-emerging hepatitis viruses. FEMS Imunol Med Microbiol. 18: 307-312.
  32. Pujol, FH y Devesa, M. 1997. Biología molecular aplicada al campo de las hepatitis virales. GEN. 51: 75-84.
  33. Hadler, SC, de Monzon, M, Ponzetto, A, et al. 1984. Delta virus infection and severe hepatitis. An epidemic in the Yucpa Indians of Venezuela. Ann Intern Med. 100:339-344.
  34. Torres, JR, y Mondolfi, A. 1997. Protracted outbreak of severe Delta Hepatitis: experience in an isolated Amerindian population of the upper Orinoco basin. Rev Infect Dis. 13: 52-55.
  35. Purcell, RH. 1994. Hepatitis viruses: Changing patterns of human disease. Proc Natl Acad Sci USA. 91: 2401-2406.
  36. Choo, Q-L, Kuo, G, Weiner, AJ, et al. 1989. Isolation of a cDNA clone derived from a blood/borne non-A, non-B viral hepatitis genome. Science. 244: 359-362.
  37. Muller, G, Zabaleta, M, Caldera, LH, Bianco, N y Machado, IV. 1990. Hepatitis C en Venezuela. Comunicación preliminar. G E N. 44:336-342.
  38. Reyes, GR, Purdy, MA, Kim JP, et al. 1990. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science. 247: 1335-1339.
  39. Ibarra, HV, Riedemann, SG, Siegel, FG, Reinhardt, GV, Toledo, CA, Frosner, G. 1994. Hepatitis E virus in Chile. The Lancet. 344:1501.
  40. Pujol, FH, Favorov, MO, Marcano, T, Esté, JA, Magris, M, Liprandi, F, Khudyakov, Y, Khudyakova, N y Fields, HA. 1994. Prevalence of antibodies against hepatitis E virus among urban and rural populations in Venezuela. J. Med. Virol.42: 234-236.
  41. Simons, JN, Leary TP, Dawson GJ, et al. Isolation of novel flavivirus-like sequences associated with human hepatitis. Nature Medicine 1995; 1: 564-9.
  42. Linnen J, Wages J, Zhang-Keck Z-Y, Fry KE, Krawczynski KZ, Alter H et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. 1996. Science. 271: 505-508.
  43. Pujol, FH, Khudyakov,YE, Devesa, M, Cong, ME, Loureiro, CL, Blitz L, Beker S, Liprandi, F y Fields, HA. 1998. Hepatitis G infection in Amerindians and other Venezuelan high-risk groups. J Clin Microbiol 36: 470-474.
  44. Alter HJ, Nakatsuji Y, Melpolder J, Wages J, Wesley R, Shih JW, Kim JP, Alter HJ et al. 1997. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med. 336: 747-754.
  45. Alter, MJ, Gallagher, M, Morris, TT, Moyer, LA, Meeks, EL, Krawczynski, K, Kim, JP y Margolis, HS. 1997. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. Sentinel Counties Viral Hepatitis Study Team. N Engl J Med. 336: 741-746.
  46. Kew, MC y Kassianides, C. 1996. HGV: hepatitis G virus or harmless G virus? Lancet 348: SII10.
  47. Bowden DS, Moaven LD y Locarnini SA. 1996. New hepatitis viruses: are there enough letters in the alphabet? Med J Australia. 164: 87-89.
  48. Nishizawa, T, Okamoto, H, Konishi, K, Yoshizawa, H, Miyakawa, Y y Mayumi, M. 1997. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun. 241:92-97.
  49. Cossart, Y. 1998. TTV a common virus, but pathogenic? Lancet. 352: 164.
  50. Loureiro, CL, Villegas, L, Blitz, L, Alonso, R, Liprandi, F y Pujol, FH. 1999. Caracterización molecular de aislados venezolanos del virus de la hepatitis G. XXVI Jornadas venezolanas de Microbiología, Valencia, Venezuela: 75.
  51. Tanaka, Y, Mizokami, M, Orito, E, Ohba, K, Nakano, T, Kato, T, Kondo, Y, Ding, X, Ueda, R, Sonoda, S, Tajima, K, Miura, T y Hayami, M. 1998. GB virus C/hepatitis G virus infection among Colombian native Indians. Am J Trop Med Hyg. 59: 462-467.
  52. Jin, L, Underhill, PA, Doctor, V, Davis, RW, Shen, P, Cavalli-Sforza, LL y Oefner, PJ. 1999. Distribution of haplotypes from a chromosome 21 region distinguishes multiple prehistoric human migrations. Proc Natl Acad Sci U S A. 96: 3796-3800.
  53. Biggar, RJ, Taylor, ME, Neel, JV, Hjelle, B, Levine, PH, Black, FL, Shaw, GM, Sharp, PM y Hahn, BH. 1996. Genetic variants of human T-lymphotrophic virus type II in American Indian groups. Virology. 216: 165-173.
  54. Leon-Ponte, M, Echeverria de Perez, G, Bianco, N, Hengst, J, Dube, S, Love, J y Poiesz, BJ. 1998. Endemic infection with HTLV-IIB in Venezuelan Indians: molecular characterization. J Acquir Immune Defic Syndr Hum Retrovirol. 17:458-464.
  55. Blitz, L, Pujol, FH, Swenson, PD, Porto, L, Atencio, R, Araujo, M, Costa, L, Callejas-Monsalve, D, Torres, JR, Fields, HA, Lambert, S, Van Geyt, C, Norder, H, Magnius, LO, Echevarría, JM y Stuyver, L. 1998. Antigenic diversity of hepatitis B virus strains of genotype F in Amerindians and other population groups from Venezuela. J. Clin. Microbiol. 36: 648-651.
  56. Planz, O, Rentzsch, C, Batra, A, Rziha, HJ y Stitz, L. 1998. Persistence of Borna disease virus-specific nucleic acid in blood of psychiatric patient. Lancet. 352: 623.
  57. Hilleman, MR. 1999. Personal historical chronicle of six decade of basic and applied research in virology, immunology, and vaccinology. Immunol Rev. 170: 7-27.
  58. Osmanov, S y Esparza, J. 1998. Development and evaluation of preventive HIV-1 vaccines. In: Saksena N: "Human Imunodeficiency Viruses: Biology, Immunology and Molecular Biology". Medical Systems, Genoa: 501-555.


Introducción
Virus emergentes
Problemática del dengue en las Américas
Otras fiebres hemorrágicas
Virus ébola
Fiebre hemorrágica venezolana
Los hantavirus
Virus influenza
Reemergencia de la encefalitis equina
VIH y la emergencia de nuevos virus
Hepatitis virales
Enfermedades crónicas de etiología desconocida
Vacunas virales en vías de emergencia
Referencias

NOTA: Toda la información que se brinda en este artículo es de carácter investigativo y con fines académicos y de actualización para estudiantes y profesionales de la salud. En ningún caso es de carácter general ni sustituye el asesoramiento de un médico. Ante cualquier duda que pueda tener sobre su estado de salud, consulte con su médico o especialista.





Instituto de Medicina Tropical - Facultad de Medicina - Universidad Central de Venezuela.
Elaborado por el Centro de Análisis de Imágenes Biomédicas Computarizadas CAIBCO,
caibco@ucv.ve
Este portal ha sido desarrollado gracias al apoyo del Fonacit